Caprospinol, Therapy for Alzheimer's Disease (AD)

 

Key Data:

Drug (Brand/Generic)
Caprospinol (SP-233)
Company/Licensee
Samaritan Pharmaceuticals
Therapy Class
Spirostenol
Product Description
Anti-amyloid agent
Current Indication
Alzheimer's disease
Market Sector
CNS
Development Status
Preclinical – IND number received from the US FDA. Phase I clinical studies yet to be started.



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development